A narrative review of peripheral blood parameters for urothelial carcinoma treated with systemic antitumor drugs

BACKGROUND AND OBJECTIVE: The prognosis of advanced urothelial carcinoma (aUC) is poor. To date, the gold standard of treatment for patients with aUC has been cisplatin-based chemotherapy. More recently, immune checkpoint inhibitors (ICIs) have been widely used for such patients, which has led to an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Takashi, Naiki, Taku, Sugiyama, Yosuke, Etani, Toshiki, Aoki, Maria, Gonda, Masakazu, Morikawa, Toshiharu, Iida, Keitaro, Tomiyama, Nami, Ando, Ryosuke, Kawai, Noriyasu, Yasui, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251088/
https://www.ncbi.nlm.nih.gov/pubmed/37305626
http://dx.doi.org/10.21037/tau-22-805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251088/
https://www.ncbi.nlm.nih.gov/pubmed/37305626
http://dx.doi.org/10.21037/tau-22-805

Ejemplares similares